Objective: Total bone marrow-derived mesenchymal stem cell (BMSC) populations differ in their potential to undergo chondrogenesis, with individual BMSCs differing in their chondrogenic capacity. The aim of this study was to explore the use of CD105 as a marker to isolate a chondrogenic subpopulation of BMSCs from the total, heterogeneous population. Design: BMSCs were isolated from patients undergoing total hip replacement and following expansion (Passage 1-Passage 5), CD105 expression was investigated by FACS analysis. FACS was also used to sort BMSCs based on the presence of CD105 (CD105+/CD105-) or their amount of CD105 expression (CD105Bright/CD105Dim). After 3 or 5 weeks of differentiation, chondrogenic potential was determined by thionine staining for glycosaminoglycan (GAG) content and by detection of collagen type II using immunohistochemistry. Results: Expanded total BMSC populations were composed almost exclusively of CD105+ cells, the percentage of which did not correlate to subsequent chondrogenic potential; chondrogenic potential was observed to diminish with culture although CD105 expression remained stable. Similarly, differences in chondrogenic potential were observed between donors despite similar levels of CD105+ BMSCs. Comparison of CD105Bright and CD105Dim BMSCs did not reveal a subpopulation with superior chondrogenic potential. Conclusions: Chondrogenic potential of BMSCs is often linked to CD105 expression. This study demonstrates that CD105 expression on culture expanded BMSC populations does not associate with a chondroprogenitor phenotype and CD105 should not be pursued as a marker to obtain a chondroprogenitor population from BMSCs.

CD105, Chondrogenesis, Chondroprogenitor, Mesenchymal stem cells, Subpopulation
dx.doi.org/10.1016/j.joca.2015.11.018, hdl.handle.net/1765/82272
Osteoarthritis and Cartilage
Department of Orthopaedics

Cleary, M.A, Narcisi, R, Focke, K, van der Linden, R, Brama, P.A.J, & van Osch, G.J.V.M. (2016). Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potential. Osteoarthritis and Cartilage, 24(5), 868–872. doi:10.1016/j.joca.2015.11.018